Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06404840
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-05-05
Brief Title:
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases A Prospective Single-Arm Phase II Study
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-05
First Submit QC Date:
May 5 2024
Study First Post Date:
2024-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-05
Last Update Post Date:
2024-05-08
Last Update Post Date Type:
ACTUAL